Zobrazeno 1 - 10
of 27
pro vyhledávání: '"A L, Berkovskiĭ"'
Publikováno v:
Stomatologiia. 93(1)
The study presents comparative analysis of porous composites made of chitosan, alginate, fibrin with beta-tricalcium phosphate. Histological findings on Wistar rat condyles showed that fibrin-beta-TCP-based composite had the most effective positive b
Autor:
A L, Berkovskiĭ, E V, Sergeeva, N D, Kachalova, I D, Gurvits, A V, Suvorov, I S, Ul'ianova, Iu G, Ivanov, A A, Kozlov
Publikováno v:
Klinicheskaia laboratornaia diagnostika. (4)
The study was undertaken to assess commercial thromboplastins for compliance to the WHO guidelines and to substantiate the validity of the results of a prothrombin test carried out using these thromboplastins. The test thromboplastins were shown to m
Autor:
A L, Berkovskiĭ, E V, Sergeeva, A V, Suvorov, L G, Mondoev, M S, Kabardina, L S, Biriukova, A A, Kozlov
Publikováno v:
Klinicheskaia laboratornaia diagnostika. (12)
The activated partial thromboplastin time (APTT) test is widely used to monitor heparin anticoagulation. The relationship of the APTT to the activity of administered unfractionated heparin was defined in 23 patients on programmed hemodialysis, by usi
Autor:
A A, Kozlov, A L, Berkovskiĭ, E V, Sergeeva, N D, Kachalova, V A, Funt, S V, Babenko, A V, Kartoshkina, E B, Orel, A V, Suvorov
Publikováno v:
Klinicheskaia laboratornaia diagnostika. (12)
The Clauss method was recommended by the WHO to measure plasma fibrinogen levels. The purpose of this study was to assess the application of test systems made by the RENAM Research-and-Production Association (Moscow) on different types of clinical la
Autor:
A L, Berkovskiĭ, E V, Sergeeva, A V, Suvorov, L A, Suvorova, I S, Ul'ianova, E B, Orel, A V, Krechetova, A A, Levina, L A, Pustovoĭt, E Iu, Saridi, G M, Galstian
Publikováno v:
Klinicheskaia laboratornaia diagnostika. (2)
Plasmin inhibitor (PI) determination is an essential diagnostic method. The purpose of the study was to develop an amidolytic assay for estimating PI activity, by applying the test system made by RENAM (Moscow). The new system is based on purified pl
Publikováno v:
Klinicheskaia laboratornaia diagnostika. (8)
Publikováno v:
Klinicheskaia laboratornaia diagnostika. (8)
A standard assay procedure for estimating antithrombin III activity was derived from the Abildgaard technique as follows: 1) to decrease errors at the preanalytical stage, by using preliminarily defibrinated lyophilized plasma-calibrator and 2) to in
Autor:
N N, Drozd, V A, Makarov, N T, Miftakhova, A L, Berkovskiĭ, E V, Sergeeva, G E, Bannikova, V P, Varlamov
Publikováno v:
Patologicheskaia fiziologiia i eksperimental'naia terapiia. (2)
It is possible to successfully determine both the activity against activated factor Xa in animals plasma after heparins administration and specific activity against activated factor Xa of new anticoagulants by means of the domestic diagnostic kit "Re
Autor:
L A, Kalashnikova, L A, Dobrynina, N L, Patrusheva, T F, Kovalenko, L I, Patrushev, E N, Aleksandrova, A L, Berkovskiĭ, E V, Sergeeva, E L, Nasonov
Publikováno v:
Terapevticheskii arkhiv. 77(10)
To study factor V Leiden, prothrombin (G1691A), 5, 10-methylenetetrahydrofolate reductase (MTHFR, C677T) mutations in patients with primary antiphospholipid syndrome (PAPS) and cerebrovascular disease (CVD).We studied 44 patients (38 female, 6 male,
Autor:
L A, Kalashnikova, A L, Berkovskiĭ, L A, Dobrynina, E V, Sergeeva, A A, Kozlov, E N, Aleksandrova, E L, Nasonov
Publikováno v:
Klinicheskaia meditsina. 81(9)
Hyperactivity of coagulation factor VIII (fVIII) marks hypercoagulation. FVIII enhances activity of factor IX and their combination activates factor X, which is of primary importance in prothrombin transformation into thrombin, on the phospholipid me